|
1) Schnabel R, Blankenberg S, Lubos E, et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res. 2005; 97: e53-9
|
|
|
|
2) Palm F, Onozato ML, Luo Z, et al. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol. 2007; 293: H3227-45
|
|
|
|
|
|
3) Achan V, Broadhead M, Malaki M, et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol. 2003; 23: 1455-9
|
|
|
|
|
|
4) Dayoub H, Achan V, Adimoolam S, et al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation. 2003; 108: 3042-7
|
|
|
|
|
|
5) Leiper J, Murray-Rust J, McDonald N, et al. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci U S A. 2002; 99: 13527-32
|
|
|
|
|
|
6) Onozato ML, Tojo A, Leiper J, et al. Expression of NG, NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers. Diabetes. 2008; 57: 172-80
|
|
|
|
|
|
7) Tojo A, Welch WJ, Bremer V, et al. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int. 1997; 52: 1593-601
|
|
|
|
|
|
8) Wang D, Gill PS, Chabrashvili T, et al. Isoform-specific regulation by N(G), N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO. Circ Res. 2007; 101: 627-35
|
|
|
|
|
|
9) Leiper J, Nandi M, Torondel B, et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med. 2007; 13: 198-203
|
|
|
|
|
|
10) Hasegawa K, Wakino S, Tatematsu S, et al. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Circ Res. 2007; 101: e2-10
|
|
|
|
|
|
11) Tojo A, Kimoto M, Wilcox CS. Renal expression of constitutive NOS and DDAH: separate effects of salt intake and angiotensin. Kidney Int. 2000; 58: 2075-83
|
|
|
|
|
|
12) Onozato ML, Tojo A, Goto A, et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 2002; 61: 186-94
|
|
|
|
|
|
13) Kakoki M, Hirata Y, Hayakawa H, et al. Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure. J Am Soc Nephrol. 2000; 11: 301-9
|
|
|
|
|
|
14) Satoh M, Fujimoto S, Haruna Y, et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol. 2005; 288: F1144-52
|
|
|
|
|
|
15) Oak JH, Cai H. Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes. 2007; 56: 118-26
|
|
|
|
|
|
16) Widder JD, Chen W, Li L, et al. Regulation of tetrahydrobiopterin biosynthesis by shear stress. Circ Res. 2007; 101: 830-8
|
|
|
|
|
|
17) Young JM, Terrin N, Wang X, et al. Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4: 1115-20
|
|
|
|
|
|
18) Tumur Z, Niwa T. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells. Am J Nephrol. 2009; 29: 551-7
|
|
|
|
|
|
19) Namikoshi T, Tomita N, Satoh M, et al. Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy. Hypertens Res. 2009; 32: 194-200
|
|
|
|
|
|
20) Shuto E, Taketani Y, Tanaka R, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009; 20: 1504-12
|
|
|
|
|
|
21) Baylis C. Sexual dimorphism in the aging kidney: differences in the nitric oxide system. Nat Rev Nephrol. 2009; 5: 384-96
|
|
|
|
|
|
22) Donato AJ, Gano LB, Eskurza I, et al. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2009; 297: H425-32
|
|
|
|
|
|
23) Pierce GL, Lesniewski LA, Lawson BR, et al. Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation. 2009; 119: 1284-92
|
|
|
|
|
|
24) Pierce GL, Beske SD, Lawson BR, et al. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension. 2008; 52: 72-9
|
|
|
|
|
|
25) Tojo A, Onozato ML, Fujita T. Role of macula densa neuronal nitric oxide synthase in renal diseases. Med Mol Morphol. 2006; 39: 2-7
|
|
|
|
|
26) Machnik A, Neuhofer W, Jantsch J, et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009; 15: 545-52
|
|
|
|
|
|
27) Kanai AJ, Pearce LL, Clemens PR, et al. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci U S A. 2001; 98: 14126-31
|
|
|
|
|
|
28) Ghafourifar P, Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol Sci. 2005; 26: 190-5
|
|
|
|
|
|
29) Brodsky SV, Gao S, Li H, et al. Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol. 2002; 283: H2130-9
|
|
|
|
|
|
30) Vinas JL, Sola A, Hotter G. Mitochondrial NOS upregulation during renal I/R causes apoptosis in a peroxynitrite-dependent manner. Kidney Int. 2006; 69: 1403-9
|
|
|
|
|
|
31) Zaobornyj T, Valdez LB, Iglesias DE, et al. Mitochondrial nitric oxide metabolism during rat heart adaptation to high altitude: effect of sildenafil, L-NAME, and L-arginine treatments. Am J Physiol Heart Circ Physiol. 2009; 296: H1741-7
|
|
|
|
|
|
32) Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006; 86: 279-367
|
|
|
|
|
|
33) Popov D, Simionescu M. Cellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium. Arch Physiol Biochem. 2006; 112: 265-73
|
|
|
|
|
|
34) Ramasamy R, Vannucci SJ, Yan SS, et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005; 15: 16R-28R
|
|
|
|
|
|
35) Tojo A, Onozato ML, Kitiyakara C, et al. Glomerular albumin filtration through podocyte cell body in puromycin aminonucleoside nephrotic rat. Med Mol Morphol. 2008; 41: 92-8
|
|
|
|
|
|
36) Eremina V, Sood M, Haigh J, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest. 2003; 111: 707-16
|
|
|
|
|
|
37) Jeansson M, Bjorck K, Tenstad O, et al. Adriamycin alters glomerular endothelium to induce proteinuria. J Am Soc Nephrol. 2009; 20: 114-22
|
|
|
|
|
|
38) Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium？ Diabetologia. 2008; 51: 714-25
|
|
|
|
|
|
39) Florian JA, Kosky JR, Ainslie K, et al. Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ Res. 2003; 93: e136-42
|
|
|
|
|
|
40) Mochizuki S, Vink H, Hiramatsu O, et al. Role of hyaluronic acid glycosaminoglycans in shear-induced endothelium-derived nitric oxide release. Am J Physiol Heart Circ Physiol. 2003; 285: H722-6
|
|
|
|
|